Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Redosing of Rimegepant for Acute Treatment of Migraine
NCT07609914Phase 4Recruiting
- Sponsor
- Pfizer
- Start
- May 2026
- Primary completion
- Jun 2028
- Countries
- 2
01
Overview
A Phase 4 trial of rimegepant in migraine, sponsored by Pfizer. Started May 2026; status: recruiting.
02
Drugs
rimegepant
03
Conditions
migraine
Beyond the preview
Go deeper on NCT07609914.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07609914.